Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular targeting: targeting angiogenesis in solid tumors

J-C Soria1, J Fayette, J-P Armand

  • 1Institut Gustave Roussy, Département de Médecine, Villejuif, France.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|October 13, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE.

ESMO open·2026
Same author

Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?

ESMO open·2023
Same author

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.

ESMO open·2023
Same author

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Intervention strategies for microbial therapeutics in cancer immunotherapy.

Immuno-oncology technology·2022